Anteilseigner
UBS Securities LLC (2,81 %) Vivo Capital LLC (2,55 %) Shay Capital LLC (1,80 %) Citadel Securities LLC (1,79 %) Sio Capital Management LLC (1,14 %) Renaissance Technologies LLC (0,78 %) Parkman Healthcare Partners LLC (0,50 %) Citadel Advisors LLC (0,38 %) Millennium Management LLC (0,36 %) FNY Capital Management LP (0,21 %) Waterfront Wealth, Inc. (0,18 %) Ikarian Capital LLC (0,16 %) Schonfeld Strategic Advisors LLC (0,12 %) Morgan Stanley & Co. LLC (0,11 %) Jane Street Capital LLC (0,10 %) Onyx Bridge Wealth Group LLC (0,10 %) Temasek Holdings Pte Ltd. (Investment Management) (0,07 %) Capital Analysts LLC (0,01 %)
Kontakt
Aslan Pharmaceuticals Ltd.